Literature DB >> 8873686

Chronopharmacokinetics of nicotine.

J M Gries1, N Benowitz, D Verotta.   

Abstract

RATIONALE: For high-clearance drugs such as nicotine, hemodynamic changes throughout the day may be expected to influence the rate of metabolism.
MATERIAL AND METHODS: To assess the effects of meals and diurnal rhythms on nicotine clearance, an intravenous infusion of nicotine bitartrate was administered for 48 hours to 11 subjects. Two models to determine nicotine clearance variation throughout the day are described. Both models were used to estimate the mean effect of meal and diurnal rhythms on nicotine clearance and individual parameters that were regressed against baseline covariates. Clearance was modeled as a function of time [CL(t)] and split it in three components: a (constant) baseline value (theta 1), its circadian (diurnal) variation, and the effect of meal: CL(t) = [theta 1 + circadian(t)] [1 + meal(t)]. A two-compartmental (time-variant) model incorporating CL(t) was then fitted to the data providing estimates of CL(t) conditional on literature values of the time-invariant parameters (volume of distribution and intercompartmental clearances).
RESULTS: The estimated circadian(t) showed a maximum at approximately 11 AM and a flat minimum from 6 PM to 3 AM; the estimated meal(t) showed a sharp increase up to 1 hour (after the meal), at which point clearance is increased 42%, and a slower decrease thereafter, returning to baseline (zero) after 2.8 hours. Individual estimates of baseline clearance are found to have a linear relationship with body weight. No other covariate, sex in particular, effect could be found.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873686     DOI: 10.1016/S0009-9236(96)90195-2

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

Review 1.  Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Authors:  Chantal Csajka; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-11       Impact factor: 2.745

Review 2.  Chronopharmacokinetics. Current status.

Authors:  B Bruguerolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

4.  Indirect pharmacodynamic models for responses with circadian removal.

Authors:  Vivaswath S Ayyar; Wojciech Krzyzanski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-01-29       Impact factor: 2.745

Review 5.  Chronopharmacokinetics of ciclosporin and tacrolimus.

Authors:  Massimo Baraldo; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Population pharmacokinetic-pharmacodynamic model of craving in an enforced smoking cessation population: indirect response and probabilistic modeling.

Authors:  R Gomeni; V Teneggi; L Iavarone; L Squassante; A Bye
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

7.  Within-day temporal patterns of smoking, withdrawal symptoms, and craving.

Authors:  Siddharth Chandra; Deborah Scharf; Saul Shiffman
Journal:  Drug Alcohol Depend       Date:  2011-02-15       Impact factor: 4.492

Review 8.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Pre- and post-nicotine circadian activity rhythms can be differentiated by a paired environmental cue.

Authors:  Andrea G Gillman; Ann E K Kosobud; William Timberlake
Journal:  Physiol Behav       Date:  2007-09-26

10.  Stability of the nicotine metabolite ratio in ad libitum and reducing smokers.

Authors:  Marc E Mooney; Zhong-Ze Li; Sharon E Murphy; Paul R Pentel; Chap Le; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.